‘Black Lives Deserves Quality Healthcare’: Gilead’s Commitment to Advancing Health and Black Equity
Gilead is no stranger to the health equity space. The 35-year-old pharmaceutical firm has developed innovative therapeutic options for people living with HIV, viral hepatitis, cancer, and other challenging conditions.